Answer
Sirturo (bedaquiline) is contraindicated in patients with hypersensitivity to the active substance or any excipient listed in section 6.1 of its Summary of Product Characteristics.
Sources for this answer
- Sirturo 100 mg tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 21Document updated
Sources checked